NO20011670L - Preparation for parenteral administration of active compounds - Google Patents

Preparation for parenteral administration of active compounds

Info

Publication number
NO20011670L
NO20011670L NO20011670A NO20011670A NO20011670L NO 20011670 L NO20011670 L NO 20011670L NO 20011670 A NO20011670 A NO 20011670A NO 20011670 A NO20011670 A NO 20011670A NO 20011670 L NO20011670 L NO 20011670L
Authority
NO
Norway
Prior art keywords
preparation
parenteral administration
active compounds
carrier material
linear
Prior art date
Application number
NO20011670A
Other languages
Norwegian (no)
Other versions
NO20011670D0 (en
Inventor
Juergen Grande
Silke Schuth
Gitte Boehm
Holger Bengs
Original Assignee
Celanese Ventures Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celanese Ventures Gmbh filed Critical Celanese Ventures Gmbh
Publication of NO20011670D0 publication Critical patent/NO20011670D0/en
Publication of NO20011670L publication Critical patent/NO20011670L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Preparat for parenteral administrering av aktive forbindelser inneholdende et bærermateriale og minst en aktiv forbindelse. Bærermaterialet inneholder sfæriske mikropartikler med gjennomsnittlig diameter på l nm til 100 um, der partiklene består utelukkende eller delvis av minst en vannuløselig lineær polysakkarid, i særdeleshet et lineært polyglukan. Oppfinnelsen angår også en suspensjon inneholdende dette prepart og anvendelse av preparatet.Preparation for parenteral administration of active compounds containing a carrier material and at least one active compound. The carrier material contains spherical microparticles having an average diameter of 1 nm to 100 µm, the particles consisting entirely or partially of at least one water-insoluble linear polysaccharide, in particular a linear polyglucan. The invention also relates to a suspension containing this prepart and the use of the formulation.

NO20011670A 1998-10-15 2001-04-03 Preparation for parenteral administration of active compounds NO20011670L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1998147593 DE19847593A1 (en) 1998-10-15 1998-10-15 Parenteral drug administration composition with depot and controlled release comprises active agent and water soluble polysaccharide microparticles as carrier
PCT/EP1999/007300 WO2000021505A2 (en) 1998-10-15 1999-10-02 Composition for the parenteral administration of active agents

Publications (2)

Publication Number Publication Date
NO20011670D0 NO20011670D0 (en) 2001-04-03
NO20011670L true NO20011670L (en) 2001-06-12

Family

ID=7884587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011670A NO20011670L (en) 1998-10-15 2001-04-03 Preparation for parenteral administration of active compounds

Country Status (8)

Country Link
EP (1) EP1124538A2 (en)
JP (1) JP2002527376A (en)
AU (1) AU6198999A (en)
CA (1) CA2346670A1 (en)
DE (1) DE19847593A1 (en)
NO (1) NO20011670L (en)
PL (1) PL347770A1 (en)
WO (1) WO2000021505A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10022095B4 (en) * 2000-05-08 2005-07-14 Südzucker AG Mannheim/Ochsenfurt Gel of a poly-α-1,4-glucan and starch
DE10119522A1 (en) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Preparation and application of a suspension composition with an ultrasound contrast medium
ES2899590T3 (en) 2004-01-23 2022-03-14 Eden Research Plc Nematode elimination methods that include the application of a terpenic component
EP2338332B1 (en) 2004-05-20 2014-02-12 Eden Research Plc Hollow glucan particle or cell wall particle encapsulating a terpene component
US20080227805A1 (en) 2007-02-28 2008-09-18 Abbott Laboratories Sustained release parenteral formulations of buprenorphine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2646879A1 (en) * 1975-10-21 1977-05-05 Takeda Chemical Industries Ltd MATRIX OF A BETA-1,3-GLUCANGEL, INSOLUBLE IN WATER, AND METHOD FOR MANUFACTURING IT
DE3045135A1 (en) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach BODEGRADABLE POLYMERS CONTAINING PHARMACEUTICAL COMPOSITIONS
PT759993E (en) * 1994-05-18 2007-08-10 Bayer Bioscience Gmbh Dna sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants, fungi and microorganisms
DE19737481A1 (en) * 1997-08-28 1999-03-04 Hoechst Ag Microparticles containing spherical linear polysaccharides
JP2002511399A (en) * 1998-04-09 2002-04-16 セラニーズ ベンチャーズ ゲー・エム・ベー・ハー Granular excipients for pulmonary administration
DE19839216C1 (en) * 1998-08-28 2000-01-20 Aventis Res & Tech Gmbh & Co Preparation of biocompatible, biodegradable water-insoluble polysaccharide microparticles, used e.g. as fillers for polymers or in diagnostic tests

Also Published As

Publication number Publication date
DE19847593A1 (en) 2000-04-20
EP1124538A2 (en) 2001-08-22
CA2346670A1 (en) 2000-04-20
PL347770A1 (en) 2002-04-22
WO2000021505A3 (en) 2000-09-21
NO20011670D0 (en) 2001-04-03
WO2000021505A2 (en) 2000-04-20
JP2002527376A (en) 2002-08-27
AU6198999A (en) 2000-05-01

Similar Documents

Publication Publication Date Title
EA199900467A2 (en) Ziprasidone formulations
DE69905380D1 (en) PHARMACEUTICAL COMPOSITIONS WITH QUICK RELEASE OF ACTIVE SUBSTANCES
ATE268167T1 (en) MULTI-PHASE PREPARATION FORMS CONTAINING ACTIVE INGREDIENTS
AU2003304237A1 (en) Gel-stabilized nanoparticulate active agent compositions
FR2831820B1 (en) ORODISPERSIBLE TABLET HAVING HIGH HOMOGENEITY AND PREPARATION METHOD THEREOF
CA2338358A1 (en) Compounds and compositions for delivering active agents
AU635358B2 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
CA2345121A1 (en) Pharmaceutical composition for the treatment of acute disorders
DE69812343D1 (en) SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULPHOALKYLETHERCYCLODEXTRIN AND A THERAPEUTIC ACTIVE SUBSTANCE
LU91613I2 (en) Paclitaxel albumin (Abraxane - paclitaxel)
ATE150310T1 (en) ORAL SUSPENSION CONSISTING OF STABILIZED ROCK POWDER OF A HYDRATED CEPHALOSPORIN
AU8796498A (en) Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine
IL164221A0 (en) Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
CA2338794A1 (en) New oral formulation for 5-ht4 agonists or antagonists
NO20011670L (en) Preparation for parenteral administration of active compounds
DE69622739D1 (en) PHARMACEUTICAL PREPARATION WITH QUICK RELEASE
AU5673399A (en) Compositions and methods for treating intracellular infections
RS50348B (en) Pharmaceutical dronedarone composition for parenteral administration
PL308838A1 (en) Pharmaceutical preparation containing cefixim as its active substance and method of stabilising such preparations
AU648890B2 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist
NO20004816L (en) New pharmaceutical formulation
NO944956D0 (en) Preparation for local application, method of preparation thereof, and use thereof
EP1086933A3 (en) Cement composition
RS50074B (en) Paracetamol and drotaverine containing composition
ATE204286T1 (en) MODIFIED ALPHA-D-GLCP-(1,2)-ALPHA-D-GLCP-(1, 3)-ALPHA-D-GLCP ANALOGUES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application